-
-
-
-
-
-
-
Praxis receives FDA breakthrough therapy designation for relutrigine
-
-
-
-
-
-
-
FDA approves GSK's SHINGRIX vaccine in prefilled syringe format
-
-
-
-
-
-
-
Oncolytics Biotech reports pelareorep immunotherapy data across tumor types
-
-
-
-
-
-
-
Nevada King reports positive phase 2 metallurgical test results at Atlanta
-
-
-
-
-
-
-
SELLAS meets Phase 2 endpoints for AML drug, receives FDA guidance
-
-
-
-
-
-
-
Gilead presents data on twice-yearly HIV prevention drug at IAS 2025
-
-
-
-
-
-
-
AstraZeneca drug meets goals in hypertension trial
-
71,212 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.